Key Record Dates Identifier: NCT01808573
Brief Title: A Study of Neratinib Plus Capecitabine Versus Lapatinib Plus Capecitabine in Patients With HER2+ Metastatic Breast Cancer Who Have Received Two or More Prior HER2 Directed Regimens in the Metastatic Setting (NALA)

First Submitted : March 4, 2013
First Submitted that Met QC Criteria : March 7, 2013
First Posted : March 11, 2013 (Estimate)

Last Update Submitted that Met QC Criteria : August 30, 2019
Last Update Posted : September 4, 2019